» Authors » Manish Ora

Manish Ora

Explore the profile of Manish Ora including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 174
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh V, Srivastava D, Kotarya N, Ora M, Gambhir S
Mol Imaging Radionucl Ther . 2025 Feb; 34(1):76-78. PMID: 39918102
A Chemoport is frequently utilized in oncological patients for administering chemotherapy. However, inadequate care can lead to various infectious and non-infectious complications. Infection commonly presents as a local infection that...
2.
Sharma S, Singh V, Gambhir S, Ora M
Indian J Nucl Med . 2025 Jan; 39(4):323-324. PMID: 39790814
Sarcoidosis is a systemic disease characterized by noncaseating granulomas involving any organ. Concurrent carcinoma breast with sarcoidosis is a rare occurrence. A 51-year-old female presented with right breast lump and...
3.
Jain B, Khandelwal Y, Ora M, Mishra P, Lal P, Gambhir S
Nucl Med Commun . 2024 Dec; 46(3):268-275. PMID: 39686667
Objective: This study aims to assess the role of 18 F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) in suspected recurrent ovarian carcinoma. Several clinical and PET parameters were assessed to evaluate disease...
4.
Soni N, Ora M, Agarwal A, Yang T, Bathla G
AJNR Am J Neuroradiol . 2024 Nov; PMID: 39572201
In recent years, generative artificial intelligence (AI), particularly large language models (LLMs) and their multimodal counterparts, Multi-Modal Large Language Models (MM-LLMs), including Vision Language Models (VLMs), have generated considerable interest...
5.
Thakare D, Singh K, Qamar T, Singh D, Balakrishnan S, Rathore U, et al.
J Inflamm Res . 2024 Nov; 17:8695-8712. PMID: 39553310
Purpose: Existing biomarkers including C-reactive protein (CRP) do not adequately distinguish active and inactive TAK. We compared serum p-glycoprotein (p-gp)/Multidrug Resistance Protein 1 (MDR1), monomeric CRP (mCRP), CRP, and mCRP:CRP...
6.
Ora M, Nazar A, Mishra P, Barai S, Arya A, Pradhan P, et al.
Nucl Med Commun . 2024 Nov; 46(1):21-27. PMID: 39506872
Background: Differentiated thyroid carcinoma (DTC) is managed by surgery followed by radioiodine (RAI) therapy in most intermediate and high-risk patients. Most nonmetastatic patients have excellent treatment responses and have long-term...
7.
Areekkara Poduvattil P, Hashim Z, Kumar S, Jain N, Ora M, Gambhir S, et al.
Echocardiography . 2024 Nov; 41(11):e15957. PMID: 39494981
Introduction: Diagnosing cardiac sarcoidosis (CS) is challenging due to the lack of a sensitive gold standard diagnostic test. Although advanced imaging techniques like cardiac magnetic resonance imaging (MRI) (cardiovascular magnetic...
8.
Soni N, Ora M, Szekeres D, Bathla G, Desai A, Gupta V, et al.
AJNR Am J Neuroradiol . 2024 Sep; PMID: 39349307
The World Health Organization Classification of Tumors of the Central Nervous System (WHO CNS5) significantly revised the terminology and diagnostic criteria of "mesenchymal non-meningothelial" tumors of CNS to better align...
9.
Ora M, Saini V, Dixit M, Singh U, Gambhir S
Indian J Nucl Med . 2024 Sep; 39(3):170-176. PMID: 39291065
Objective: Biochemical recurrence (BCR) after initial management of Prostate Carcinoma (PC) is frequent. Subsequent interventions rely on disease burden and metastasis distribution. Ga prostate-specific membrane antigen positron emission tomography/computed tomography...
10.
Singh V, Srivastava D, Kotarya N, Ora M, Pradhan P
Asia Ocean J Nucl Med Biol . 2024 Jul; 12(2):189-201. PMID: 39050233
Peritoneal carcinomatosis (PC), the spread of cancer cells in the peritoneum, is a significant concern in advanced gastrointestinal and gynecological cancers. This case series includes findings on the appearance and...